In the British Journal of Cancer this week, researchers in the US and Europe describe their comparison of three methods for detecting KRAS mutations in preserved colorectal cancer samples. The team used the Cobas KRAS Mutation Test, the Qiagen Therascreen KRAS Kit, and Sanger sequencing on 120 colorectal cancer samples, and found that the Cobas test detected six mutations not found by Sanger sequencing and eight mutations not found by the Qiagen kit.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.